Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
3,332.40
+86.00 (2.65%)
Apr 23, 2025, 3:30 PM IST
Torrent Pharmaceuticals Revenue
Torrent Pharmaceuticals had revenue of 28.09B INR in the quarter ending December 31, 2024, with 2.82% growth. This brings the company's revenue in the last twelve months to 113.02B, up 7.90% year-over-year. In the fiscal year ending March 31, 2024, Torrent Pharmaceuticals had annual revenue of 107.28B with 11.51% growth.
Revenue (ttm)
113.02B
Revenue Growth
+7.90%
P/S Ratio
9.99
Revenue / Employee
7.19M
Employees
15,718
Market Cap
1,128.50B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 107.28B | 11.08B | 11.51% |
Mar 31, 2023 | 96.20B | 11.12B | 13.07% |
Mar 31, 2022 | 85.08B | 5.03B | 6.29% |
Mar 31, 2021 | 80.05B | 652.60M | 0.82% |
Mar 31, 2020 | 79.39B | 2.67B | 3.47% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |
Torrent Pharmaceuticals News
- 4 weeks ago - Torrent Pharmaceuticals issues Rs 300 crore worth of commercial papers at 7.13% discount rate - Business Upturn
- 2 months ago - Torrent Pharmaceuticals Ltd (BOM:500420) Q3 2025 Earnings Call Highlights: Strong India Growth ... - GuruFocus
- 2 months ago - Q3 2025 Torrent Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Top Q3 Results Tomorrow, January 24: HPCL, JSW Steel, IndiGo, Torrent Pharma, Godrej Consumer Products, Shriram Finance and more - Business Upturn
- 5 months ago - Pharma stocks weekly roundup: Biocon leads with 9.08% gain, Torrent Pharma up 4.91%, Lupin dips 1.82% - Business Upturn
- 5 months ago - Torrent Pharmaceuticals market cap rises Rs 3,450 crore - Business Upturn
- 5 months ago - Torrent Pharma receives EIR from USFDA for Pithampur facility - Business Upturn
- 5 months ago - Torrent Pharma shares rise nearly 3% after receiving EIR from USFDA - Business Upturn